shortagewatch

Home / Duloxetine / Italy

IT ATC N06AX21 · updated 2 Nov 2026

Duloxetine shortage in Italy

Is there a Duloxetine shortage in Italy?

Yes. As of 2 Nov 2026, 15 Duloxetine products are reported short in Italy, the first since 30 Sep 2024. The company estimate for the return is 31 Dec 2026. Main reason: manufacturing problem.

Also short in Canada, Germany, France, Spain, Ireland, Austria, Belgium, Czechia, Sweden, Japan, Australia. All countries.

Affected products in Italy

CountryProductCompanySinceExpected backReason
ITDULOXETINA ZENTIVAZENTIVA K.S.30 Sep 2024not givenManufacturing problem
Problemi produttivi: forniture discontinue
ITDULOXETINA ZENTIVAZENTIVA K.S.30 Sep 2024not givenManufacturing problem
Problemi produttivi: forniture discontinue
ITDULOXETINA VIATRISVIATRIS LIMITED1 Nov 2024not givenIncreased demand
Elevata richiesta/problemi produttivi
ITDULOXETINA SANDOZSANDOZ S.P.A.5 Dec 2024not givenManufacturing problem
Problemi produttivi
ITDULOXETINA SANDOZSANDOZ S.P.A.5 Dec 2024not givenManufacturing problem
Problemi produttivi
ITDULOXETINA SANDOZSANDOZ S.P.A.5 Dec 2024not givenManufacturing problem
Problemi produttivi
ITDULOXETINA VIATRISVIATRIS LIMITED1 Jan 2025not givenIncreased demand
Elevata richiesta/problemi produttivi
ITDULOXETINA EGEG S.P.A.31 Oct 2025not givenManufacturing problem
Problemi produttivi
ITDULOXETINA ALMUSALMUS S.R.L.17 Nov 202531 Dec 2026Manufacturing problem
Problemi produttivi
ITDULOXETINA ALMUSALMUS S.R.L.17 Nov 202531 Dec 2026Manufacturing problem
Problemi produttivi
ITDULEXECUPHARMA S.R.L.7 Jan 2026not givenManufacturing problem
Problemi produttivi
ITDULOXETINA VIATRISVIATRIS LIMITED1 Mar 2026not givenManufacturing problem
Problemi produttivi
ITDULEXECUPHARMA S.R.L.13 Apr 2026not givenManufacturing problem
Problemi produttivi
ITDULEXECUPHARMA S.R.L.31 Aug 2026not givenManufacturing problem
Problemi produttivi
ITDULOXETINA ZENTIVA anticipatedZENTIVA K.S.30 Apr 2027not givenManufacturing problem
Problemi produttivi

Source

AIFA (Italian Medicines Agency), licensed CC-BY 4.0. Official list. All shortages reported by marketing-authorisation holders, including medicines being withdrawn.